Intra-aortic balloon pumping has recently been shown to be ineffective in treating cardiogenic shock due to myocardial infarction. Other, more potent percutaneous pumps have been developed, and their ...
More than a quarter of patients with early-stage cardiogenic shock had to be transferred to a higher level of care, progressed to a worse stage of shock, or died, according to a study in six US ...
TEEN4 Pharmaceuticals GmbH today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to invobenitug (formerly known as procizumab), for the treatment of ...
New clinical guidance to help cardiologists navigate the complexity of cardiogenic shock and assess possible cases within the first hour after onset introduces a memory aid — SUSPECT — which stands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results